Results 11 to 20 of about 35,270 (248)

Comprehensive evaluation of risk factors for the development and complications of chemotherapy-induced febrile neutropenia [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2022
Febrile neutropenia is a serious adverse effect of chemotherapy. It can lead to complications and death, as well as delays in treatment, chemotherapy dose reductions, compromised treatment efficacy, and reduced survival.
Dimitrijević Jelena   +3 more
doaj   +1 more source

Prophylaxis and management of chemotherapy-induced febrile neutropenia: The role of myeloid growth factors [PDF]

open access: yesMedicinski Podmladak, 2022
Febrile neutropenia is a serious chemotherapy-related adverse event that can lead to complications and death and it could be a significant burden on the organization of the health care system.
Dimitrijević Jelena, Stojanović Marko
doaj   +1 more source

Empiric Imipenem/Cilastatin/Relebactam for Febrile Neutropenia After Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports [PDF]

open access: yesJournal of Blood Medicine
Dao-Xing Deng,* Ting Wang,* Hui Sun,* Jun Kong, Yuan-Yuan Zhang, Le-Qing Cao, Xiao-Dong Mo Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center
Deng DX   +6 more
doaj   +2 more sources

Febrile neutropenia in the emergency department

open access: yesCurrent Medical Issues, 2021
Introduction: Febrile neutropenia is one of the most common presentations to the emergency department. Identification and empirical antibiotic therapy improve the outcome of these patients.
Malle Simeon   +2 more
doaj   +1 more source

Carbapenems and febrile neutropenia [PDF]

open access: yesClinical Microbiology and Infection, 2017
International ...
Alfandari, S.   +2 more
openaire   +4 more sources

Diagnostics and therapy of paediatric patients with febrile neutropenia [PDF]

open access: yes, 2023
Febrile neutropenia is a common infectious complication in children and adolescents receiving chemotherapy for cancer, requiring immediate hospitalisation and empirical antibacterial therapy.
Lehrnbecher, Thomas   +3 more
core   +1 more source

Factors associated with hospital length of stay among cancer patients with febrile neutropenia. [PDF]

open access: yesPLoS ONE, 2014
PURPOSE:This study sought to evaluate factors associated with hospital length of stay in cancer patients with febrile neutropenia. METHODS:A prospective cohort study was performed at a single tertiary referral hospital in southern Brazil from October ...
Regis G Rosa, Luciano Z Goldani
doaj   +1 more source

Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer [PDF]

open access: yes, 2012
Background: Febrile neutropenia is a frequently occurring and occasionally life-threatening complication of treatment for childhood cancer. Many biomarkers have been proposed as predictors of adverse events.
Phillips Robert S   +19 more
core   +1 more source

Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case presentation

open access: yesThe Pan African Medical Journal, 2021
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single low-dose methotrexate for the treatment of ectopic ...
Burak Bayraktar
doaj   +1 more source

Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy : systematic review and meta-analysis [PDF]

open access: yes, 2011
Background: Febrile neutropenia (FN) occurs following myelosuppressive chemotherapy and is associated with morbidity, mortality, costs, and chemotherapy reductions and delays.
Akehurst Ron L   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy